Extensive research on soluble CD44 (SolCD44) in saliva as an early detection tool for head and neck squamous cell carcinoma (HNSCC) has been carried out by Elizabeth J. Franzmann et al. [38,44]. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.